About NewBridge Pharmaceuticals
NewBridge Pharmaceuticals is a specialty pharmaceutical company based in Dubai. Its business model focuses on bringing innovative and specialty medicines from international companies to patients in the Middle East, Turkey and Africa.
Many pharmaceutical and biotech companies, especially smaller and mid-sized ones, do not have their own presence in every country. Companies like NewBridge partner with them, licensing the rights to register, market and distribute their medicines in the region.
This involves several steps. Medicines must be registered with the health authority in each country, which requires regulatory expertise and local dossiers. Once approved, the company handles marketing to doctors and hospitals, distribution and pharmacovigilance, which means monitoring the safety of medicines after they reach patients.
Specialty medicines often treat complex or rare conditions in areas such as oncology, rare diseases, immunology and neurology. Bringing them to new markets can give patients access to treatments that were not previously available.
The Middle East and Africa are growing pharmaceutical markets, with rising healthcare spending and governments investing in health systems.
Dubai's free zones, logistics infrastructure and connectivity make it a natural base for regional pharmaceutical companies, with healthcare clusters such as Dubai Science Park hosting many of them.
Startups UAE lists NewBridge Pharmaceuticals among the UAE's healthcare and pharmaceutical companies.
Many pharmaceutical and biotech companies, especially smaller and mid-sized ones, do not have their own presence in every country. Companies like NewBridge partner with them, licensing the rights to register, market and distribute their medicines in the region.
This involves several steps. Medicines must be registered with the health authority in each country, which requires regulatory expertise and local dossiers. Once approved, the company handles marketing to doctors and hospitals, distribution and pharmacovigilance, which means monitoring the safety of medicines after they reach patients.
Specialty medicines often treat complex or rare conditions in areas such as oncology, rare diseases, immunology and neurology. Bringing them to new markets can give patients access to treatments that were not previously available.
The Middle East and Africa are growing pharmaceutical markets, with rising healthcare spending and governments investing in health systems.
Dubai's free zones, logistics infrastructure and connectivity make it a natural base for regional pharmaceutical companies, with healthcare clusters such as Dubai Science Park hosting many of them.
Startups UAE lists NewBridge Pharmaceuticals among the UAE's healthcare and pharmaceutical companies.